Key Calls (Tuesday): Upgrades, Downgrades & Initiations

 

 

 

 

 

 

 


1580572w


 

Yesterday’s Analysts Actions Recap



(Bloomberg) — Changes since prior close.

Upgrade

UPGRADES:

  • Access National (ANCX) upgraded to outperform at KBW; PT $34
  • Amphenol (APH) upgraded to buy at Goldman; PT $108
  • Assembly Bio (ASMB) upgraded to buy at B Riley FBR; Price Target $42
  • BPY-U CN (BPY-U CN) upgraded to outperform at Evercore ISI
  • BRP Inc (DOO CN) upgraded to outperform at RBC; Price Target C$70
  • Baker Hughes (BHGE) upgraded to buy at Jefferies
  • CenterPoint Energy (CNP) upgraded to outperform at Wells Fargo; PT $30
  • Conagra (CAG) upgraded to buy at UBS; PT Set to $40
  • Cree (CREE) upgraded to neutral at JPMorgan; Price Target $35
  • Dominion Energy (D) upgraded to overweight at JPMorgan; PT $78
  • Ensco (ESV) upgraded to outperform at Wells Fargo; PT $11
  • GE (GE) upgraded to overweight at Barclays; Price Target $16
  • Hartford Financial (HIG) upgraded to buy at BofAML; PT Set to $59
  • Houghton Mifflin (HMHC) upgraded to outperform at BMO; Price Target $8
  • Hovnanian (HOV) upgraded to market perform at JMP
  • International Speedway (ISCA) upgraded to neutral at Citi; PT $38
  • Kosmos Energy (KOS) upgraded to buy at Investec
  • LMAT US (LMAT) raised to outperform at Barrington Research; PT $34
  • LeMaitre Vascular (LMAT) upgraded to buy at Roth Capital; PT $34
  • Loxo Oncology (LOXO) upgraded to outperform at IFS Securities; PT $190
  • Malvern Bancorp (MLVF) upgraded to buy at Sandler O’Neill; PT $24
  • Monmouth Real Estate (MNR) upgraded to buy at B Riley FBR; PT $17
  • Movado (MOV) upgraded to outperform at Cowen; Price Target $50
  • On Deck Capital (ONDK) upgraded to neutral at BTIG
  • PSEG (PEG) upgraded to buy at Citi; PT $60
  • PayPal (PYPL) upgraded to buy at DZ Bank; Price Target $90
  • Petrobras ADRs (PETR4 BZ) upgraded to outperform at Bradesco BBI; PT $20
  • Petrobras ADRs (PETR4 BZ) upgraded to overweight at JPMorgan; PT $17
  • Scana (SCG) upgraded to buy at Mizuho; Price Target $43
  • Southern Copper (SCCO) upgraded to neutral at Citi
  • Summit Midstream Partners (SMLP) upgraded to buy at Goldman
  • Walmart (WMT) upgraded to buy at Deutsche Bank
  • Willis Towers (WLTW) upgraded to outperform at Credit Suisse; PT $166

Downgrade

DOWNGRADES:

  • Beacon Roofing (BECN) downgraded to market perform at William Blair
  • Blackbaud (BLKB) downgraded to hold at Benchmark
  • Blackbaud (BLKB) downgraded to hold at Stifel; PT $88
  • Blackbaud (BLKB) downgraded to market perform at JMP
  • Blackbaud (BLKB) downgraded to market perform at Raymond James
  • Carlisle (CSL) downgraded to market perform at BMO; PT $125
  • Cision Ltd. (CISN) downgraded to hold at Deutsche Bank
  • Cogent Comms (CCOI) downgraded to neutral at BTIG
  • Coherent (COHR) downgraded to neutral at Longbow
  • Coherent (COHR) downgraded to neutral at Northcoast
  • CommScope (COMM) downgraded to neutral at Goldman; PT $32
  • Continental Resources (CLR) cut to market perform at BMO; PT $73
  • Ericsson ADRs (ERICB SS) downgraded to underperform at Raymond James
  • Exelon (EXC) downgraded to neutral at Citi; Price Target $45
  • Exelon (EXC) downgraded to neutral at JPMorgan; PT $48
  • Glu Mobile (GLUU) downgraded to neutral at Roth Capital; PT $8
  • Guidewire (GWRE) downgraded to hold at Deutsche Bank
  • IPG Photonics (IPGP) downgraded to neutral at Northcoast
  • International Paper (IP) downgraded to market perform at BMO; PT $51
  • Jeld-Wen (JELD) downgraded to neutral at Baird; PT $23
  • Kimberly-Clark (KMB) downgraded to neutral at Goldman
  • Kroger (KR) downgraded to sell at Deutsche Bank
  • MPLX (MPLX) downgraded to neutral at Goldman
  • Magellan Midstream (MMP) downgraded to neutral at Goldman
  • ManpowerGroup (MAN) downgraded to neutral at Macquarie; PT $91
  • Melco Resorts ADRs (MLCO) downgraded to hold at China Renaissance
  • Mohawk Industries (MHK) downgraded to underweight at JPMorgan; PT $160
  • Mylan (MYL) downgraded to equal-weight at Morgan Stanley; PT $36
  • PPG Industries (PPG) downgraded to neutral at Baird; PT $115
  • Packaging Corp (PKG) downgraded to market perform at BMO; PT $108
  • SemGroup (SEMG) downgraded to sell at Goldman
  • Smart & Final (SFS) downgraded to hold at Deutsche Bank
  • Taylor Morrison (TMHC) downgraded to market perform at JMP
  • Trinity Industries (TRN) cut to hold at Spin-Off Research; PT $42
  • Union Bankshares (UBSH) downgraded to neutral at Compass Point; PT $41
  • Waters (WAT) downgraded to market perform at Leerink Partners; PT $190
  • WestRock (WRK) downgraded to market perform at BMO; PT $54
  • Whirlpool (WHR) downgraded to neutral at JPMorgan; PT $122
  • Whiting Petroleum (WLL) downgraded to equal- weight at Capital One
  • iRobot (IRBT) downgraded to neutral at Piper Jaffray; Price Target $90
  • nLight (LASR) downgraded to neutral at Northcoast

INITIATION

INITIATIONS:

  • 111 ADRs (YI) rated new overweight at JPMorgan; PT $16
  • Addus HomeCare (ADUS) rated new outperform at RBC; PT $81
  • Allergan (AGN) rated new buy at Guggenheim
  • Alliant Energy (LNT) rated new neutral at Mizuho; PT $44
  • Apollo Commercial (ARI) rated new neutral at BTIG
  • Apple (AAPL) rated new sell at Vertical Group; PT $175
  • Aptiv (APTV) rated new outperform at Macquarie; PT $103
  • Arbor Realty Trust (ABR) rated new buy at BTIG; PT $12.50
  • Arcus Biosciences (RCUS) rated new outperform at Wedbush; PT $22
  • Ares Commercial (ACRE) rated new buy at BTIG; PT $15
  • Auris Medical Holding AG (EARS) new buy at Alliance Global Partners
  • Blackstone Mortgage (BXMT) rated new neutral at BTIG
  • Boot Barn (BOOT) rated new outperform at William Blair
  • Box (BOX) rated new hold at Deutsche Bank; PT $22
  • Braskem ADRs (BRKM5 BZ) resumed at bofaml with Neutral; PT $32
  • Bristol-Myers (BMY) rated new neutral at Guggenheim
  • Bruker (BRKR) rated new sell at UBS; PT $30
  • CQP (CQP) rated new neutral at Goldman
  • Cabot Corp (CBT) rated new overweight at Barclays; PT $76
  • Catalent (CTLT) rated new neutral at UBS; PT $48
  • Charles River (CRL) rated new neutral at UBS; PT $140
  • Cheniere Energy (LNG) rated new neutral at Goldman
  • City Office REIT (CIO) rated new market outperform at JMP; PT $14
  • Criteo ADRs (CRTO) rated new neutral at DA Davidson; PT $25
  • Danaher (DHR) rated new buy at UBS; PT $125
  • Energy Transfer Equity (ETE) rated new buy at Goldman
  • Enterprise Products (EPD) rated new neutral at Goldman
  • Euronet (EEFT) rated new buy at Citi; PT $135
  • Exact Sciences (EXAS) rated new buy at UBS; PT $100
  • Exantas Capital Corp (XAN) rated new buy at BTIG; PT $13
  • First Data (FDC) resumed at deutsche bank With Buy; PT $29
  • Fortis Inc (FTS CN) rated new buy at BofAML; PT C$45
  • Garrett Motion (GTX) rated new equal-weight at Barclays; PT $16
  • Granite Point Mortgage Trust (GPMT) rated new neutral at BTIG
  • Hologic (HOLX) rated new neutral at UBS; PT $44
  • Icon (ICLR) rated new sell at UBS; PT $145
  • Illumina (ILMN) rated new neutral at UBS; PT $340
  • Intuit (INTU) rated new buy at Deutsche Bank; PT $265
  • Iqvia (IQV) rated new buy at UBS; PT $160
  • Kemet (KEM) rated new outperform at Macquarie; PT $25
  • Kinder Morgan (KMI) rated new buy at Goldman
  • Lantronix (LTRX) rated new buy at Needham; PT $5.50
  • Liberty Health Sciences (LHS CN) rated new speculative buy at Canaccord
  • Liberty-Formula One (FWONA) rated new neutral at Goldman; PT $39
  • Lilly (LLY) rated new buy at Guggenheim
  • ManTech (MANT) rated new neutral at Alliance Global Partners; PT $63
  • Mav Beauty Brands (MAV CN) rated new sector perform at National Bank
  • Merck & Co (MRK) rated new buy at Guggenheim; PT $84
  • Methanex (MX CN) rated new equal-weight at Barclays
  • Mettler-Toledo (MTD) rated new neutral at UBS; PT $625
  • Molecular Templates (MTEM) rated new buy at Laidlaw; PT $18
  • NIO Inc. ADRs (NIO) rated new buy at Deutsche Bank; PT $9.50
  • NIO Inc. ADRs (NIO) rated new neutral at Citi; PT $7.20
  • NIO Inc. ADRs (NIO) rated new neutral at Goldman; PT $6.56
  • NIO Inc. ADRs (NIO) rated new neutral at JPMorgan; PT $7.50
  • NIO Inc. ADRs (NIO) rated new overweight at Morgan Stanley; PT $8.50
  • NN (NNBR) rated new neutral at Baird; PT $17
  • NanoString (NSTG) rated new buy at UBS; PT $23
  • Oneok Inc (OKE) rated new neutral at Goldman
  • PRA Health (PRAH) rated new neutral at UBS; PT $115
  • Penumbra (PEN) rated new outperform at RBC; PT $174
  • PerkinElmer (PKI) rated new neutral at UBS; PT $100
  • Principia Biopharma (PRNB) rated new buy at BofAML; PT $33
  • Principia Biopharma (PRNB) rated new outperform at Baird; PT $50
  • Principia Biopharma (PRNB) rated new outperform at Leerink Partners
  • Principia Biopharma (PRNB) rated new outperform at Wells Fargo; PT $45
  • Qutoutiao ADRs (QTT) rated new overweight at KeyBanc; PT $11
  • Ready Capital Corp (RC) rated new buy at BTIG; PT $18
  • RingCentral (RNG) rated new buy at Deutsche Bank; PT $105
  • Spring Bank Pharma (SBPH) rated new buy at Jefferies; PT $28
  • Syneos Health (SYNH) rated new buy at UBS; PT $60
  • TC PipeLines (TCP) rated new sell at Goldman
  • TPG RE Finance Trust (TRTX) rated new buy at BTIG; PT $21.50
  • TTM Tech (TTMI) rated new outperform at Macquarie; PT $20
  • Tallgrass Energy LP (TGE) rated new buy at Goldman
  • Teladoc (TDOC) rated new neutral at Credit Suisse; PT $80
  • Tesla (TSLA) rated new outperform at Macquarie; PT $430
  • Thermo Fisher (TMO) rated new buy at UBS; PT $295
  • Tower Semiconductor (TSEM IT) rated new buy at Jefferies; PT $30
  • Trade Desk (TTD) rated new buy at DA Davidson; PT $158
  • TransCanada (TRP CN) rated new neutral at Goldman
  • Trulieve Cannabis (TRUL CN) rated new speculative buy at Canaccord
  • Twilio (TWLO) rated new buy at Deutsche Bank; PT $88
  • Veoneer (VNE) rated new neutral at Macquarie; PT $53
  • Waters (WAT) rated new neutral at UBS; PT $210
  • Williams Cos (WMB) rated new neutral at Goldman
  • Yext Inc. (YEXT) rated new buy at DA Davidson; PT $28
  • Zendesk (ZEN) rated new buy at Deutsche Bank; PT $85
  • iQIYI ADRs (IQ) rated new buy at Jefferies; PT $33

 

-R.W.N II, yours in 322.

vibrato-stripes-c2014-paul-ashby

Banyan Capital Management, LLC (“BCM”) is a publisher, not a registered investment advisor, and nothing in BCM’s newsletter is intended, and it should not be construed, to be investment advice. BCM’s newsletter is for informational use only. Any mention in BCM’s newsletter of a particular security, index, derivative, or other instrument is neither a recommendation by BCM to buy, sell, or hold that security, index, derivative, or other instrument, nor does it constitute an opinion of BCM (or of any of its officers, employees, agents or representatives) as to the suitability of that security, index, derivative or other instrument for any particular purpose. BCM is not in the business of giving investment advice or advice regarding the suitability for any purpose of any security, index, derivative, other instrument or trading strategy and nothing in BCM’s newsletter should be so used or relied upon. BCM is not acting as your financial advisor nor in a fiduciary capacity, with regard to any securities, index, derivative or other instrument referred to in BCM’s newsletter. Also, no representation is made concerning the tax implications in any applicable jurisdiction regarding any securities, index, derivative or other instrument and BCM is not advising you in respect of the tax implications. All opinions and estimates in the newsletters are given as of the date of their publication on the BCM’s website and are subject to change and BCM does not assume any obligation to update the newsletters or to reference any such changes. BCM hereby expressly disclaims any and all representations and warranties that: (a) the content of its newsletters is correct, accurate, complete, reliable or a guaranty of future performance; (b) any of its newsletters will be available at any particular time or place, or in any particular medium; and (c) that any omission or error in any of its newsletters will be corrected. BCM shall not be liable for any errors or omissions made in its newsletters or for any inaccuracies in its assumptions. BCM specifically disclaims liability for any losses or damages (incidental, consequential or otherwise) that may arise from the newsletters and that are either used or relied upon by anyone for any reason, including without limitation, the use of the newsletters in the preparation of any financial books and records. Although from time to time BCM’s newsletter may link to or promote others’ websites or services, BCM is not responsible for and does not control those websites or services. BCM’s newsletter is published and distributed in accordance with applicable United States and foreign copyright and other laws. Without the prior written consent of BCM, no person or entity, directly or indirectly, may copy, reproduce, recompile, decompile, disassemble, reverse engineer, distribute, publish, display, perform, modify, upload to create derivative works from, transmit, or in any way exploit all or any part of BCM’s website, its newsletter, or any other material belonging to BCM.Without the prior written consent of BCM, no person or entity, directly or indirectly, may offer all or any part of BCM’s website, its newsletter, or any other material belonging to BCM for sale, nor may any person or entity, directly or indirectly, distribute all or any part of BCM’s website, its newsletter, or any other material belonging to BCM over or by means of any medium.Without the prior written consent of BCM, no person or entity, directly or indirectly, may make all or any part of BCM’s website, its newsletter, or any other material belonging to BCM, available as part of or in connection with another website, whether by hyperlink, framing on the Internet or otherwise. At any given time BCM’s principals may or may not have a financial interest in any or all of the securities and instruments discussed herein. At any given time BCM’s principals may or may not have a financial interest in any or all of the securities and instruments discussed herein.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.